These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 2296571)
1. Longitudinal CT evaluation of transdermal scopolamine for aspiration pneumonia with sialorrhea in severe chronic brain injury: A case series. Yamaki T; Takahashi K; Azuhata O; Itou D; Yakufujiang M; Oka N; Odaki M; Kobayashi S SAGE Open Med Case Rep; 2022; 10():2050313X221096227. PubMed ID: 35548103 [TBL] [Abstract][Full Text] [Related]
7. Transdermal scopolamine in the prevention of motion sickness at sea. Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021 [TBL] [Abstract][Full Text] [Related]
8. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy. Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736 [TBL] [Abstract][Full Text] [Related]
10. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. Nachum Z; Shupak A; Gordon CR Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539 [TBL] [Abstract][Full Text] [Related]
11. Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning. Parrott AC Aviat Space Environ Med; 1989 Jan; 60(1):1-9. PubMed ID: 2647072 [TBL] [Abstract][Full Text] [Related]